Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7870057rdf:typepubmed:Citationlld:pubmed
pubmed-article:7870057lifeskim:mentionsumls-concept:C0025011lld:lifeskim
pubmed-article:7870057lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:7870057lifeskim:mentionsumls-concept:C0042717lld:lifeskim
pubmed-article:7870057lifeskim:mentionsumls-concept:C0079600lld:lifeskim
pubmed-article:7870057lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:7870057pubmed:issue1lld:pubmed
pubmed-article:7870057pubmed:dateCreated1995-3-27lld:pubmed
pubmed-article:7870057pubmed:abstractTextThe generation of a sustained antibody response requires the participation of MHC class II-restricted T helper cells. We have identified class II-restricted sequences by immunizing BALB/c (H-2d) mice with 108 overlapping synthetic pentadecapeptides covering the whole sequence of the measles virus fusion protein (MV-F). Several strong T cell epitopes were found including a major cluster of H-2d-restricted peptides between amino acids 256 and 305. Some of these peptides including peptide F(421-435) and F(256-270) induced MV-specific T lymphocytes in vivo while other H2d-restricted MV-F sequences did not. Immunization with mixtures of selected peptides indicated a hierarchy among H2d-restricted sequences due to competition between peptides. The dominant peptide F(421-435) impaired the response to other T cell epitopes including F(256-270). The response to F(91-105) was obliterated by F(421-435) and F(256-270) but not by peptides devoid of a T cell epitope. When BALB/c mice were immunized with the MV, the immunodominant sequence F(421-445) was identified which included the synthetic peptide F(421-435). Our data suggest that competition during processing and/or presentation between H2d-restricted peptides defines the immunodominant sequence of the viral protein. Even though only a single immunodominant region was defined after immunization with the MV, peptides from other regions were able to induce MV-specific T cell responses. This finding is of interest for the design of subunit vaccines in general and for studying MV-specific T helper cells in an animal model in particular.lld:pubmed
pubmed-article:7870057pubmed:languageenglld:pubmed
pubmed-article:7870057pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7870057pubmed:citationSubsetIMlld:pubmed
pubmed-article:7870057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7870057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7870057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7870057pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7870057pubmed:statusMEDLINElld:pubmed
pubmed-article:7870057pubmed:monthJanlld:pubmed
pubmed-article:7870057pubmed:issn0161-5890lld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:SchneiderFFlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:JungGGlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:BronsN HNHlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:WiesmüllerK...lld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:MullerC PCPlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:WeinmannMMlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:AmmonSSlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:GanderRRlld:pubmed
pubmed-article:7870057pubmed:authorpubmed-author:MayserHHlld:pubmed
pubmed-article:7870057pubmed:issnTypePrintlld:pubmed
pubmed-article:7870057pubmed:volume32lld:pubmed
pubmed-article:7870057pubmed:ownerNLMlld:pubmed
pubmed-article:7870057pubmed:authorsCompleteYlld:pubmed
pubmed-article:7870057pubmed:pagination37-47lld:pubmed
pubmed-article:7870057pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:meshHeadingpubmed-meshheading:7870057-...lld:pubmed
pubmed-article:7870057pubmed:year1995lld:pubmed
pubmed-article:7870057pubmed:articleTitleIntramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein.lld:pubmed
pubmed-article:7870057pubmed:affiliationLaboratoire National de Santé, Luxembourg.lld:pubmed
pubmed-article:7870057pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7870057pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7870057lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7870057lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7870057lld:pubmed